Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities - Quiz - MDSpire

Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • By

  • Lidetian Hu

  • Haixing Cao

  • Yujie Zhang

  • Xiang Ma

  • July 15, 2026

Share

Original Source(s)

Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • by Lidetian Hu, Haixing Cao, Yujie Zhang, Xiang Ma

  • July 15, 2026

Related Content

Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab

Feasibility and acceptability of FinCare: A personalized online tool for estimating out-of-pocket costs for cancer treatment

Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer